Skinvisible's DermSafe(R) Hand Sanitizer Kills Swine... (s such as H1N1 ('swine flu') H3N2 and H5...)

Skinvisible's DermSafe(R) Hand Sanitizer Kills Swine Flu Virus

Date:4/28/2009

s such as H1N1 ('swine flu'), H3N2 and H5N1 ('avian bird flu virus')," said Mr. Terry Howlett, President and CEO of Skinvisible. "We are confident that DermSafe can offer protection for people concerned about spreading germs from person to person and we will continue to undertake more studies on these and other viruses."

The active ingredient in DermSafe is chlorhexidine, which has been used in hospitals worldwide for over fifty years as a pre-surgical hand scrub. DermSafe is available for licensing both commercially in healthcare and food services as well as for personal use (retail) worldwide. DermSafe has been approved for distribution by Health Canada and the company is implementing a plan to seek FDA approval in the US and worldwide.

About Invisicare

Invisicare is Skinvisible's patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. It is a combination of hydrophilic and hydrophobic polymers that hold active ingredients on the skin for extended periods of time resisting both wash off and perspiration. Invisicare can control the release of actives, reduce irritation and can eliminate some costly manufacturing processes. It is non-occlusive and allows for normal skin respiration while protecting against environmental irritants. www.invisicare.com

About Skinvisible Pharmaceuticals, Inc

Skinvisible Pharmaceuticals is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the Invisicare patent. Skinvisible's value also lies
'/>"/>

SOURCE Skinvisible, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. SkinWear(TM) Hand Cleaner & Sanitizer Kills Germs That May Cause Swine Flu, Protects Against Germs for Up to Eight Hours
2. ReStockIt.com Greatly Cutting Prices on Hand Sanitizers, Masks to Help Combat Swine Flu Epidemic
3. It Pays to Use Prevention This Cold & Flu Season With Help From NOZIN(R) Nasal Sanitizer(R)
4. Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work
5. Palliative care skills training needed for health-care staff in sub-Saharan Africa
6. Study finds students with Experience Corps tutors make 60 percent more progress in critical reading skills
7. New Coaching Program Helps Charge Nurses Develop Leadership Skills: B. E. Smith's Coaches Develop High Performers Who Improve Hospital Finances
8. Active Ingredient in Marijuana Kills Brain Cancer Cells
9. TV Watching Doesnt Fast-Track Babys Skills
10. Paving the Way for Peace in the Middle East with Mind-Body Skills
11. Young People Want Happily Ever After, but Lack Skills to Make Marriage Work

Post Your Comments:

(Date:5/21/2013)... 21, 2013 Dr. Francine Kaufman , inventor ... used with her patients in the 1980s: It weighed several pounds ... the most part, it could only be used in the hospital ... since then, and the advantages are greater as well. The insulin ... of the body, often on a belt or a pocket. It ...

(Date:5/21/2013)... Atlanta, GA (PRWEB) May 21, 2013 ... Care, ScripNet and Procura Management, today announced that ... Award at Catamaran’s client advisory meeting. Conferred ... has partnered with Catamaran to create cutting edge ... This year, Healthcare Solutions was recognized for its ...

(Date:5/21/2013)... Healthcare industry leaders, health information technology startups, and ... Emerging Healthcare Technology Conference, June 10 at the Fluno ... new event is part of the 11th annual Digital ... being held June 10-12 at the Fluno Center for ... for healthcare information technology (IT) grew dramatically in 2012 ...

(Date:5/21/2013)... 21, 2013 Two-thirds of patients who ... lung cancer reported that they engage in at least ... according to new findings from the National Health ... Health . The research will be presented today at ... for Pharmacoeconomics and Outcomes Research) in New Orleans. ...

(Date:5/21/2013)... May 21, 2013 The producers of ... air dates for Peterborough, Ontario, Canada. The area is famous ... for Canadians and Americans. It is located an hour from ... Peterborough is located in the Kawartha Hills, home to several ... economic stability to the area. Residents and visitors to this ...

Breaking Medicine News(10 mins):Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 2 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 3 Health News:Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives 4 Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2 Health News:“Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet 2 Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2 Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3 Health News:Net Worth Business TV Announces May Air Dates for Peterborough, Ontario 2

[0] Kaufman Shows People With Diabetes How to Use New Technology to Improve Their Lives [0] Healthcare Solutions Receives Innovation Award From Catamaran [0] “Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet [0] Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research [0] Net Worth Business TV Announces May Air Dates for Peterborough, Ontario

... Annual Dinner, May 17, DETROIT, Jan. 31 ... its nurse paging system, thanks to the,generosity of ... vice,president of development for the Institute., (Logo:, ... our 26th Annual Dinner May 17, Ford Motor ...

... Long-time local partners cite proprietary research, strategic planning and ... superior creative as keys to their success, ... two major,national advertising awards at the Consumer Health World Conference ... have again taken top honors in a national awards program., ...

... once looked at for cancer, also attacks the human immunodeficiency ... research published today online in the open access journal Retrovirology. ... learned to hide out in certain human cells where it ... serve as viral reservoirs. Operating from these havens, the virus ...

... ABAX ), a medical products company manufacturing point-of-care,blood analysis ... 31, 2007., Highlights for the third ... $25.7 million, up 17% over last year,s comparable quarter. ... over last year,s comparable quarter. ...

... Separate Research Confirms Part D Seniors Also Enjoy Broad ... Pharmaceutical Care,Management Association (PCMA) issued the following statement on ... drug benefit is lower over the,next ten years than ... saving money without sacrificing beneficiaries,choice of prescription drugs. New ...

... of its ongoing efforts to do whatever it takes ... for Parkinson,s disease, The Michael J. Fox Foundation for ... total funding to four industry teams seeking to push ... awards were granted under MJFF,s Therapeutics Development Initiative (TDI) ...

Ford Motor Company Fund Continues Longtime Support to Cancer Care St.Vincent and Publicis Indianapolis Receive National Service Industry Advertising Awards Anti-parasite drug may provide new way to attack HIV Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 CMS: Part D Costs $117 Billion Lower Than Expected Michael J. Fox Foundation awards up to $3 million to industry teams

(Date:5/21/2013)... May 21, 2013 Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...

(Date:5/21/2013)... ORLANDO, Fla. , May 21, 2013 /PRNewswire/ ... and safety results from the global Phase 3 ... protease inhibitor simeprevir (TMC435) led to sustained virologic ... (SVR12) in 79 percent of treatment-experienced genotype 1 ... disease, including all stages of liver fibrosis, when ...

(Date:5/21/2013)... 21, 2013 Abaxis, Inc. (NasdaqGS: ABAX), a ... today that Martin Mulroy , chief ... Dental & Veterinary Conference on Wednesday, May 29, 2013 ... at Le Parker Meridien Hotel in New ... Abaxis develops, manufactures, markets and sells portable blood ...

Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2 New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6 Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7 Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2

[0] New Data Validates CyberKnife SBRT for Prostate Cancer Treatment [0] Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients [0] Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference

... Results from the Phase II portion of a ... for the treatment of acute heart failure will be ... at the American College of Cardiology,s (ACC) 58th Annual ... of medicine, University of California San Francisco , ...

... Will Test Ability of Adecatumumab to Prolong Disease ... MetastasesBETHESDA, Md., March 23 Micromet, ... company developing novel, proprietary antibodies for the treatment ... the commencement of a randomized, controlled phase 2 ...

Cached Medicine Technology:Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session 2 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 2 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 3 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 4 Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 5

Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients

...

Tip is bent towards port for downward irrigation. 25G x 5/8in (.50 x 22mm)...

... product designed for LASIK surgery and other ... the corneal interface and/or stromal bed. Flattened ... and helps elevate the flap edge. Multiple ... G (.40 x 22mm). Angled 90 degrees, ...

... LASIK surgery and other types of ... corneal interface and/or stromal bed. Flattened ... flap and helps elevate the flap ... 23G x 7/8in (.60 x 22mm) ...

Medicine Products:

Hydrodissector - Daya Irrigating Cystotome - Reverse Lasik Irrigator - Probst Lasik Spatula/Irrigator